Adell Harriman & Carpenter’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,355
Closed -$557K 134
2019
Q1
$557K Sell
2,355
-2,221
-49% -$699K 0.11% 96
2018
Q4
$1.38M Sell
4,576
-89
-2% -$28.4K 0.3% 76
2018
Q3
$1.65M Sell
4,665
-261
-5% -$89.9K 0.31% 73
2018
Q2
$1.43M Sell
4,926
-1,245
-20% -$350K 0.28% 75
2018
Q1
$1.69M Sell
6,171
-255
-4% -$79.2K 0.35% 72
2017
Q4
$2.05M Buy
6,426
+200
+3% +$64.2K 0.43% 62
2017
Q3
$1.95M Buy
6,226
+315
+5% +$93.3K 0.43% 62
2017
Q2
$1.6M Sell
5,911
-989
-14% -$262K 0.36% 67
2017
Q1
$1.89M Sell
6,900
-377
-5% -$107K 0.43% 63
2016
Q4
$2.06M Sell
7,277
-1,551
-18% -$460K 0.51% 63
2016
Q3
$2.76M Buy
8,828
+420
+5% +$124K 0.7% 53
2016
Q2
$2.03M Buy
8,408
+608
+8% +$160K 0.53% 57
2016
Q1
$2.03M Buy
7,800
+3,130
+67% +$827K 0.55% 57
2015
Q4
$1.43M Buy
4,670
+1,325
+40% +$381K 0.38% 69
2015
Q3
$976K Buy
3,345
+550
+20% +$182K 0.29% 77
2015
Q2
$1.13M Sell
2,795
-10
-0.4% -$4.01K 0.29% 80
2015
Q1
$1.18M Buy
2,805
+1,605
+134% +$633K 0.31% 81
2014
Q4
$407K Buy
+1,200
New +$388K 0.11% 105

Other funds holding BIIB

Adell Harriman & Carpenter's BIIB Position: Q2 2019 in Review

Adell Harriman & Carpenter sold out of Biogen (BIIB) in Q2 2019, closing a stake of 2,355 shares — an estimated $557K sold.

Adell Harriman & Carpenter first reported a position in BIIB in Q4 2014 and held it in 18 quarters. The position peaked at $2.76M in Q3 2016. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Adell Harriman & Carpenter reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Adell Harriman & Carpenter sold 2,355 Biogen shares in Q2 2019, an estimated $557K.
  • Adell Harriman & Carpenter first reported a position in Biogen in Q4 2014 and held it in 18 quarters.
  • Adell Harriman & Carpenter's Biogen position peaked at $2.76M in Q3 2016.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Adell Harriman & Carpenter's 13F filing for Q2 2019, filed 7 Aug 2019.